Stocks and Investing
Stocks and Investing
Thu, October 6, 2016
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
Geoff Meacham Downgraded (ALNY) to Hold and Decreased Target to $50 on, Oct 6th, 2016
Geoff Meacham of Barclays, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold and Decreased Target from $85 to $50 on, Oct 6th, 2016.
Geoff has made no other calls on ALNY in the last 4 months.
There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Geoff's Rating of Hold.
This is the rating of the analyst that currently disagrees with Geoff
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $83 on, Friday, August 5th, 2016
Contributing Sources
Similar Stocks and Investing Articles
[ Fri, Aug 05th 2016
] - WOPRAI
[ Tue, Nov 10th 2015
] - WOPRAI
[ Mon, Nov 02nd 2015
] - WOPRAI
[ Wed, Oct 28th 2015
] - WOPRAI
[ Tue, Aug 11th 2015
] - WOPRAI
[ Fri, Aug 07th 2015
] - WOPRAI
[ Fri, Aug 07th 2015
] - WOPRAI
[ Fri, Feb 27th 2015
] - WOPRAI
[ Fri, Oct 18th 2013
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI